(19)
(11) EP 4 823 562 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24828778.1

(22) Date of filing: 12.12.2024
(51) International Patent Classification (IPC): 
A61K 31/341(2006.01)
A61K 45/06(2006.01)
A61K 9/48(2006.01)
A61K 31/7076(2006.01)
A61P 21/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/341; A61K 45/06; A61K 31/7076; A61P 21/04; A61K 9/4808; A61K 9/2054; A61K 9/2018
 
C-Sets:
  1. A61K 31/341, A61K 2300/00;
  2. A61K 31/7076, A61K 2300/00;

(86) International application number:
PCT/EP2024/086103
(87) International publication number:
WO 2025/125527 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 14.12.2023 US 202363610175 P
10.06.2024 US 202463658170 P
06.08.2024 US 202463679861 P

(71) Applicant: Ares Trading S.A.
1170 Aubonne, VD (CH)

(72) Inventors:
  • BECKER, Andreas Werner
    64293 Darmstadt (DE)
  • RAVULA, Abhigyan
    Billerica, Massachusetts 01821 (US)
  • GOTETI, Kosalaram
    Billerica, Massachusetts 01821 (US)
  • ALEXANDRI, Nektaria
    64293 Darmstadt (DE)
  • BOSCHERT SHAFAATIAN, Ursula
    1262 Eysins (CH)
  • KOEHL, Niklas Julian
    64293 Darmstadt (DE)
  • VON BURKERSRODA, Friederike
    64293 Darmstadt (DE)
  • WIEDEY, Raphael
    64293 Darmstadt (DE)
  • ASSI, Pardis
    Craigavon Armagh BT63 5QD (GB)
  • JUNG, Markus
    64293 Darmstadt (DE)

(74) Representative: Merck Serono S.A. Intellectual Property 
Terre Bonne Business Park Building Z0 Route de Crassier 1
1262 Eysins
1262 Eysins (CH)

   


(54) CLADRIBINE REGIMEN FOR TREATING MYASTHENIA GRAVIS